Aosaikang's Limertinib Approved for EGFR T790M-Mutated NSCLC
CompanyDrug

Aosaikang’s Limertinib Approved for EGFR T790M-Mutated NSCLC

Johnson & Johnson Submits NDA for TAR-200 in High-Risk Bladder Cancer
CompanyDrug

Johnson & Johnson Submits NDA for TAR-200 in High-Risk Bladder Cancer

Eli Lilly's Omvoh Approved by FDA for Crohn's Disease Treatment
CompanyDrug

Eli Lilly’s Omvoh Approved by FDA for Crohn’s Disease Treatment

IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline
CompanyDeals

IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline

Boehringer Ingelheim's Iclepertin Fails to Meet Phase III Study Endpoints
CompanyDrug

Boehringer Ingelheim’s Iclepertin Fails to Meet Phase III Study Endpoints

Telix Pharmaceuticals' TLX591-CDx Approved in Europe via Decentralized Procedure
CompanyDrug

Telix Pharmaceuticals’ TLX591-CDx Approved in Europe via Decentralized Procedure

NMPA Implements Regulatory Reforms for Drug and Medical Device Industries
Policy / Regulatory

NMPA Implements Regulatory Reforms for Drug and Medical Device Industries

Daiichi Sankyo Acquires Gatipotuzumab IP Rights for $132.5M
CompanyDeals

Daiichi Sankyo Acquires Gatipotuzumab IP Rights for $132.5M

NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance
Policy / Regulatory

NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance

a16z Bio + Health Launches Biotech Ecosystem Venture Fund
CompanyDeals

a16z Bio + Health Launches Biotech Ecosystem Venture Fund

Impact Therapeutics' Senaparib Cleared by NMPA for Ovarian Cancer Therapy
CompanyDrug

Impact Therapeutics’ Senaparib Cleared by NMPA for Ovarian Cancer Therapy

Siemens Lays Foundation for New Medical Equipment Base in Shenzhen
Company

Siemens Lays Foundation for New Medical Equipment Base in Shenzhen